Executive Director, Regulatory Policy and Intelligence
POLITICO's AgencyIQ
Alexander Gaffney is the Executive Director of Regulatory Policy and Intelligence at AgencyIQ, the regulatory analysis division of POLITICO, where he founded and leads the team’s research and analysis of regulatory issues affecting pharmaceutical, biotechnology, medical device and chemical companies.
Before joining AgencyIQ, Alexander analyzed regulations as part of PricewaterhouseCoopers's Health Research Institute and was the Manager of Regulatory Intelligence at the Regulatory Affairs Professionals Society (RAPS), where he also served as Managing Editor for the company’s flagship publication, Regulatory Focus. Alexander is regularly asked to speak to executive audiences about life science regulatory policy developments and his work (including his daily newsletter, FDA Today) is relied upon by many of the country's top life sciences companies, law firms, trade associations, regulatory professionals and public health officials. He has a master’s degree in Regulatory Science and his Regulatory Affairs Certification (RAC) in US regulation.
Disclosure information not submitted.
Wednesday, October 4, 2023
2:00 PM – 3:00 PM EDT
Wednesday, October 4, 2023
3:30 PM – 4:30 PM EDT
Sponsored Presentation: FDA Forecast: The Biggest Issues Facing the FDA in 2024
Thursday, October 5, 2023
11:15 AM – 11:40 AM EDT